While we confirm expression of CAMK1D and CDC123 in islets and hepatocytes, future studies over-expressing the target gene(s) in these tissues would be necessary to establish the mechanisms by which increased expression leads to diabetes risk. This evidence concerns the gene CDC123 and diabetes mellitus.